Fantoni A, Warburton L, Solomon B, Alexander M, et al. Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT). Clin Lung Cancer 2024 Apr 15:S1525-7304(24)00051.
PMID: 38705835